In a clinical trial investigating mother-to-child HIV transmission in South Africa researchers find that adding two other antiretroviral drugs to single dose nevirapine — an antiretroviral drug given to women and newborn children during labor and delivery to prevent transmission — is effective in reducing the drug resistance that nevirapine causes when used by itself.